Polyclonal anti-tumor necrosis factor-α Fab used as an ancillary treatment for severe malaria

Single doses (250, 500, 1,000, or 2,000 units/kg) of an ovine polyclonal-specific Fab fragment directed against tumor necrosis factor-α (TNF-α) were given to 17 adult patients with severe falciparum malaria immediately before treatment with artesunate in a pilot study to assess safety and optimal do...

Full description

Saved in:
Bibliographic Details
Main Authors: S. Looareesuwan, L. Sjostrom, S. Krudsood, P. Wilairatana, R. S. Porter, F. Hills, D. A. Warrell
Other Authors: Mahidol University
Format: Article
Published: 2018
Subjects:
Online Access:https://repository.li.mahidol.ac.th/handle/123456789/25479
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Mahidol University